Stay updated on Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision history shows the addition of Revision: v3.4.3 and the removal of Revision: v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedVersion history now shows a new Revision: v3.4.2, and older funding notices were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and the revision tag v3.4.1; removed the previous revision tag v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a structured Record History with Study Record Versions and a comprehensive change log, including the latest update on 2025-05-06 noting termination of the study. This enables viewing and comparing past versions to understand how the study record has evolved.SummaryDifference31%

- Check62 days agoChange DetectedRecord History now lists Revision: v3.3.4, replacing v3.3.3.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry 'Revision: v3.3.3' appears in the record history. The footer links for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.SummaryDifference0.1%

Stay in the know with updates to Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.